H7N9 Influenza
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (NCT06417853) | Vaxxas Pty Ltd | 2024-07-31 |
| A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03755427) | Shanghai Institute Of Biological Products | 2018-11-10 |
| Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil (NCT03330899) | Butantan Institute | 2018-09-24 |
| A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03369808) | Shanghai Institute Of Biological Products | 2017-12-29 |
| Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years (NCT01928472) | Novartis Vaccines | 2013-08-01 |
Track H7N9 Influenza automatically
Every clearance here is in the API, with alerts when new ones post.